Personal Care Products

SOFTCARE

China Merchants Securities First Coverage and Strongly Recommends Le Shufu

UBS Analyst Reiterates Buy Rating on Softcare Limited

UBS Initiates Coverage of Luxurious at Buy Rating with Target Price of HKD41

CICC First Coverage of La Redoute Comfort with an Outperform Rating

GTHT Securities Upgrades Lu Cheng Shu to Overweight

Lek Sou Si Expresses Oversubscription Warrant Rights to Raise Additional HKD 360 Million

Luxury Comfort's Over-allotment Option Fully Exercised Involving 13,632,600 Shares

Luxuryskin IPO Over-subscribed by more than 690 times

SOFTCARE released FY2024 Annual Earnings on October 30, 2025 (BJT), with actual revenue of HKD 3.541 B and EPS of HKD 1.4824

SOFTCARE released FY2022 Annual Earnings on October 30, 2025 (BJT), actual revenue HKD 2.505 B, actual EPS HKD 0.288

SOFTCARE released FY2023 annual earnings on October 30 (BJT), actual revenue HKD 3.222 B, actual EPS HKD 1.013

Prudence Investment Management (Hong Kong) Limited increased its holdings in Weiqiao Textile

< 1B

1B - 5B

5B - 10B

10B - 50B

50B - 100B

100B - 500B

500B - 1T

≥ 1T

Market Value

Total Assets

< 100M

100M - 500M

500M - 1B

≥ 100B

Revenue

0 - 50M

50M - 100M

≥ 10B

Profits

< 0%

0% - 5%

5% - 10%

10 - 15%

15% - 20%

20 - 25%

25% - 30%

>= 30%

ROE(TTM)

= 0%

0% - 1%

1% - 3%

3% - 5%

5% - 8%

8% - 10%

>= 10%

Dividend Yield

0% - 10%

10% - 15%

20% - 30%

30% - 40%

40% - 50%

>= 50%

Net Profit Margin

0 - 0.05

0.05 - 0.1

0.1 - 0.2

0.2 - 0.4

0.4 - 0.6

0.6 - 0.8

0.8 - 1

>= 1

Asset Turnover

< 1.5

1.5 - 2

2 - 3

3 - 5

5 - 10

10 - 15

15 - 20

>= 20

Equity Multiplier

< 10%

10% - 30%

30% - 50%

50% - 70%

70 - 80%

80% - 90%

90% - 95%

>= 95%

Debt Ratio

UNI PRINTSHOP

WING CHI HLDGS

CINESE INTL

WAN KEI GROUP

CHINA WACAN

JH EDUCATION

DIGITAL DOMAIN

LOTUS HORIZON

VICO INTL HLDGS

K W NELSON GP

MAO GEPING

GIANT BIOGENE

CHICMAX

MING FAI INT'L

SINOLIFE UTD

BAWANG GROUP

CH GOLD CLASSIC

HENGAN INT'L

GOLDEN THROAT

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

02698

CGS International has maintained a Buy rating on Softcare Limited (2698) as of February 6, with a price target of HK$38.00. The stock closed at HK$31.10. The analyst consensus for Softcare is a Strong Buy, with an average price target of HK$40.09, indicating a potential upside of 28.91%. UBS also supports this with a Buy rating and a price target of HK$41.00.

Tip Ranks

Softcare Limited (2698) Receives a Buy from CGS International

UBS analyst Charles Eden has reaffirmed a Buy rating on Softcare Limited (2698) with a price target of HK$41.00, while the shares closed at HK$33.28. The analyst consensus for Softcare is Strong Buy, with a price target consensus of HK$40.61. Eden has an average return of -2.5% and a 44.25% success rate on his stock recommendations.

UBS Reaffirms Their Buy Rating on Softcare Limited (2698)

Softcare Limited has announced a change of compliance adviser, terminating its agreement with Soochow Securities effective January 12, 2026, due to personnel changes. Ping An of China Capital will take over as the new compliance adviser, ensuring oversight of post-listing compliance obligations. This appointment reflects Softcare's commitment to regulatory compliance. The latest analyst rating for Softcare's stock (HK:2698) is a Buy with a price target of HK$31.22.

Softcare Switches Compliance Adviser to Ping An Following Personnel Change at Soochow

SOFTCARE (2698.HK) performed strongly yesterday, with funds pushing the stock price close to the key range of 143 yuan, testing the pressure in that area multiple times during the session. The pharmaceutical and medical sector saw a partial warming at the beginning of January, with market funds focusing on changes in industry pricing power and the performance elasticity brought by the implementation of cooperation agreements. Recently, leading companies in the niche market where SOFTCARE operates announced new cooperation agreements, triggering a renewed acceleration of fund rotation in the sector, with some low-priced varieties receiving major institutional accumulation

Technical Forecast

Morning Trend | SOFTCARE funds push close to resistance level, short-term opportunities emerge in the pharmaceutical sector?

Guotai Haitong analyst maintained a Buy rating on Softcare Limited yesterday and set a price target of HK$40.36. The company’s shares closed last Monday at HK$31.76.Claim 70% Off TipRanks This Holiday SeasonUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Currently, the analyst consensus on Softcare Limited is a Moderate Buy with an average price target of HK$40.47.

Guotai Haitong Sticks to Its Buy Rating for Softcare Limited (2698)

CICC analyst maintained a Buy rating on Softcare Limited yesterday and set a price target of HK$40.00.Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential Currently, the analyst consensus on Softcare Limited is a Moderate Buy with an average price target of HK$40.47.

Softcare Limited (2698) Gets a Buy from CICC

SOFTCARE announced that on December 5th, the overall coordinator fully exercised the 15% over-allotment option, involving a total of 13.6326 million shares. The offering price was HKD 26.2, with additional net proceeds of HKD 345 million. In addition, the stabilization period for the global offering ended on the same day. During this period, the stabilization agent, China International Capital Corporation, did not buy or sell any shares in the market

AASTOCKS

SOFTCARE fully exercised its over-allotment option, raising an additional 345 million

Guosheng Securities analyst maintained a Buy rating on Softcare Limited yesterday and set a price target of HK$40.94.TipRanks Cyber Monday Sale Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off Softcare Limited has an analyst consensus of Hold.

Softcare Limited (2698) Receives a Buy from Guosheng Securities

SOFTCARE (2698.HK) faced significant pressure during trading yesterday, with a substantial increase in trading volume throughout the day, indicating a proactive outflow of market funds. Affected by the overall sluggishness of the consumer sector, investor confidence in related consumer stocks has been undermined, leading to a dominant presence of proactive selling during the session, causing the stock price to fluctuate downward. Coupled with the recent domestic consumption data showing no significant recovery, the short-term risk aversion sentiment for SOFTCARE has become more pronounced, with some external funds choosing to wait and see or actively withdraw. 

From a technical perspective, a MACD daily death cross signal has formed, with the momentum histogram continuing to shrink, and the short-term support level has been effectively breached, indicating a significant increase in trading pressure on the right side of the technical chart. Meanwhile, the loosening of chips during the session and an increase in turnover rate suggest that previous holders are taking action to exit. Although some funds are attempting to buy at low levels, the overall increase in volume combined with oversold releases highlights a clear short-term bottom-seeking characteristic. The market is currently still observing whether there will be new stimuli or marginal benefits from policy, and if there is a continued lack of fund inflow and optimistic expectations, a phase of bottom-seeking and competition for the bottom is unavoidable. 

Investors need to pay attention to the next policy direction and whether sector sentiment will reach an inflection point, and must strictly control risks in their operations to avoid increasing positions against the trend, while also being wary of volatility triggered by intraday fluctuations. In the long term, the recovery of the company's fundamentals and the warming of consumer confidence remain key factors affecting whether the trend can be reversed. Overall, SOFTCARE still faces short-term pressure, with intensified competition in the bottom area, and patience is required to wait for trading opportunities after risk release

Morning Trend | SOFTCARE sees increased volume and declines, is a bottom battle coming?

Hong Kong Stocks Gain on China Data; Softcare Jumps in Debut

marketscreener

Hong Kong Stocks Gain on China Data; Softcare Jumps in Debut

SOFTCARE Limited was listed in Hong Kong, opening at HKD 34.98, up 33.5% from the offering price, and closing at HKD 34.46 at noon, an increase of 31.5%. The public offering was oversubscribed by 1,813 times, and the international placement was oversubscribed by 33.3 times, raising a net amount of HKD 2.229 billion. The funds raised will mainly be used to expand production capacity, upgrade production lines, and for marketing promotion

BambooWorks

Brief News: SOFTCARE's first listing closed up 32% with an oversubscription of 1,813 times

SOFTCARE debuted on its first day, opening at HKD 34.98, up 33.5% from the listing price of HKD 26.2. The highest/lowest prices were HKD 36.8/HKD 33.36, closing at HKD 34.46, up 31.5% from the listing price of HKD 26.2. The half-day trading volume was 32.1165 million shares, involving HKD 1.128 billion

"New Stocks" SOFTCARE closed at 34.46 yuan for half a day, up 31.5% from the listing price

Softcare, an Africa-focused hygiene-products maker, saw its shares jump 34% on its Hong Kong debut, opening at HK$34.98 compared to the offer price of HK$26.20. The IPO raised HK$2.38 billion, with a retail subscription rate of 1,813.77 times. The company, which produces baby diapers and sanitary pads, reported a revenue increase of 10.5% to US$454.4 million in 2024, and a net profit surge of 47% to US$95.1 million. Proceeds from the IPO will be used for expanding production capacity and strengthening brand efforts.

南华早报

Africa-focused hygiene-products maker Softcare’s shares jump 34% on Hong Kong debut

Ownership	%Owned	Share Chg	Report Date
Chaoyuet Holding Limited	54.75%	No Change	10/12/2025
Jichao Luo	5.69%	No Change	10/12/2025
Guangzhou Shufan Enterprise	2.14%	No Change	10/12/2025
Renwei Zhou	1.14%	No Change	10/12/2025
FMR LLC	0.75%	No Change	28/11/2025
Goldman Sachs Asset Management, L.P.	0.01%	No Change	31/12/2025

SOFTCARE(02698.HK)

Financial Score

Valuation analysis

Institutional View & Shareholder

Analyst Ratings

Softcare Limited (2698) Receives a Buy from CGS International

UBS Reaffirms Their Buy Rating on Softcare Limited (2698)

Softcare Switches Compliance Adviser to Ping An Following Personnel Change at Soochow

Morning Trend | SOFTCARE funds push close to resistance level, short-term opportunities emerge in the pharmaceutical sector?

Guotai Haitong Sticks to Its Buy Rating for Softcare Limited (2698)